Varenicline and Nicotine Interactions in Humans (VA)

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2009

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline

Varenicline (1 mg per day) given for 4 days prior to laboratory session

DRUG

Placebo

Sugar Pill

DRUG

IV Nic

IV Nicotine given during the laboratory session following 4 days of exposure to the study medication (varenicline or placebo). This nicotine was given during each laboratory session which followed the 4 days of exposure to either placebo then varenicline or varenicline then placebo.

Trial Locations (1)

06516

Veterans Affairs Hospital, West Haven

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00606892 - Varenicline and Nicotine Interactions in Humans (VA) | Biotech Hunter | Biotech Hunter